Quinoxaline N , N ′-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi . Structure–activity relationships-Reference-Cited by-同舟云学术

Quinoxaline N , N ′-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi . Structure–activity relationships

Published:2004-07 Issue:14 Volume:14 Page:3835-3839
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Aguirre Gabriela,Cerecetto Hugo,Di Maio Rossanna,González Mercedes,Alfaro Marı́a Elena Montoya,Jaso Andrés,Zarranz Belén,Ortega Miguel Ángel,Aldana Ignacio,Monge-Vega Antonio

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference39 articles.

1. http://www.who.int/ctd/chagas

2. Moncayo, A. In Eleventh Programme Report of the UNPD: World Bank: WHO Special Program for Research and Training in Tropical Diseases (TDR), Geneva: World Health Organization, 1993; pp 67–75

3. Basic Cell Biology of Trypanosoma cruzi

4. Detection of an ?epimastigote-like? intracellular stage ofTrypanosoma cruzi

5. Trypanosoma cruzi: Characterization of an Intracellular Epimastigote-like Form

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development;Pharmaceuticals;2023-08-17

2. Design, synthesis, characterization, bioactivity and molecular docking studies of novel sulfamides;Studia Universitatis Babeș-Bolyai Chemia;2023-06-30

3. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies;Future Medicinal Chemistry;2022-06

4. Quinoxaline 1,4-di-N-oxides: a review of the importance of their structure in the development of drugs against infectious diseases and cancer;Medicinal Chemistry Research;2021-05-05

5. Synthesis and Structure-Chirality Relationship Analysis of Steroidal Quinoxalines to Design and Develop New Chiral Drugs;Chemistry;2021-03-15